NFE2L2 and cardiomyopathy: These indicated that fisetin (20 mg/kg/day and 40 mg/kg/day) attenuated ADR-induced cardiomyopathy by inhibiting ferroptosis through SIRT1/Nrf2 signaling pathway activation [87].